Maximizing the Public Health Benefit of Adverse Event Collection Throughout a Products Marketed Life Cycle; Public Workshop

2 organizations filed 2 public comments on Maximizing the Public Health Benefit of Adverse Event Collection Throughout a Products Marketed Life Cycle; Public Workshop, at the Food and Drug Administration. The comment window closed 6724d ago.

Abstract

Docket Status: OPEN

Commenters (2)

• American Pharmacists Association (APhA)trade assoc.

  1 filing · confidence 97%
• National Alliance for Breastfeeding Advocacytrade assoc.

  1 filing · confidence 85%